Increased Bladder Apoptosis with α-1 Adrenoceptor Antagonists in Benign Prostatic Hyperplasia

Abstract

Objective: To determine whether preoperative usage of &#102 -1 adrenoceptor antagonists ( &#102 -1ARA) prevents the alterations in bladder wall components due to obstruction via changing apoptotic and/or proliferative activity and provides an advantage for improvement of irritative symptoms following removement of bladder outlet obstruction. Material and Methods: A total of 39 patients were enrolled to the present study. According to preoperative medical treatment, patients were divided into 2 groups as preoperative untreated (n = 15) and medically treated patients with &#102 -1ARA (n = 24). Apoptotic and proliferative indices of bladder wall were determined with TUNEL assay and proliferating cell nuclear antigen immunoreactivity, respectively. Results: While the mean apoptotic indexes (AI) of lamina propria were 0.293 &#45 0.163 vs 0.978 &#45 0.194 in untreated and treated patients, the mean AI of myofibroblast cells were 0.10 &#45 0.06 and 0.90 &#45 0.23 in untreated and treated patients, respectively. There were statistically significant differences between lamina propria (p = 0.0067) and myofibroblast cells (p = 0.0280) AI in the two groups. However, there were no significant differences between postoperative symptom indices in preoperatively treated and untreated groups. Conclusions: &#102 1-ARA treatment might have an effect on hypertrophy and supersensitivity of bladder wall due to increased outlet obstruction via prevention of the imbalance between cell proliferation and apoptosis, providing normal homeostatic control mechanisms, through the interval between the onset of the lower urinary tract symptoms and time surgical intervention. However, further studies should be organized to demonstrate the impact of long-term &#102 1-ARA medication for post-operative significant improvement on irritative symptom index.

• Alpha-ADRENOCEPTOR Antagonists
• Apoptosis
• Benign Prostatic Hyperplasia
• Bladder